CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Matthias E. Liechti - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Matthias E. Liechti

OPENALEX: A5071962736↗ORCID: 0000-0002-1765-9659↗

Affiliations

Organizations

University Hospital of Baselauthorship · CH University of Baselauthorship · CH

Public evidence

4 connected articles

Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity: A Euro-DEN Plus Study2023 · PubMed Central Open Access Designer drugs: mechanism of action and adverse effects.2020 · Europe PMC Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.2016 · PubMed Central Open Access To Dope or Not to Dope: Neuroenhancement with Prescription Drugs and Drugs of Abuse among Swiss University Students2013 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.